WHERE ARE YOU?
A sister publication of MedDeviceCyber.com
Saturday, September 5, 2026
Updated every morning. Free. No login.
THE TAPE
Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register
The Directory // Dental

Dental

Dental implants, aligners, imaging and chairside tools. 2 companies listed.

San Francisco, CA  ·  Est. 2013  ·  Unknown

Sells software orthodontists use to design clear aligners and 3D print them in their own offices.

Boston, MA  ·  Est. 2020  ·  Unknown

Combines optical imaging, AI and robotics to automate tooth preparation and other dental procedures.

One email, every morning
THE MORNING BRIEF

New clearances, funding rounds and regulatory moves for device founders. No noise, no login.

You're in. The next morning brief lands in your inbox.

Unsubscribe anytime. We never sell the list.